Nanjing Hicin Pharmaceutical Co.,Ltd.’s Net Profit Dropped 1.9% in First Quarter of 2023

Nanjing Hicin Pharmaceutical Co.,Ltd. (南京海辰药业股份有限公司) (300584.SZ) reported a net profit of 12.2 million yuan in the first quarter of 2023, down 1.9% year-on-year.

Meanwhile, the company posted 117.2 million yuan in revenue, down 22.2% year-on-year.

At the end of the reporting period, it had 1.3 billion yuan in total assets and 370.9 million yuan in total liabilities, with a liability-to-asset ratio of 27.8%.